nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2B6—Raloxifene—osteoporosis	0.0518	0.0736	CbGbCtD
Cyclophosphamide—CYP2B6—Ethinyl Estradiol—osteoporosis	0.05	0.0711	CbGbCtD
Cyclophosphamide—CYP2C9—Estropipate—osteoporosis	0.041	0.0583	CbGbCtD
Cyclophosphamide—CYP2B6—Cholecalciferol—osteoporosis	0.04	0.0568	CbGbCtD
Cyclophosphamide—CYP2C8—Raloxifene—osteoporosis	0.0392	0.0557	CbGbCtD
Cyclophosphamide—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0379	0.0538	CbGbCtD
Cyclophosphamide—CYP3A7—Estradiol—osteoporosis	0.0338	0.0481	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0338	0.0481	CbGbCtD
Cyclophosphamide—CYP2C8—Cholecalciferol—osteoporosis	0.0303	0.043	CbGbCtD
Cyclophosphamide—ABCB1—Ethinyl Estradiol—osteoporosis	0.0256	0.0364	CbGbCtD
Cyclophosphamide—CYP2C19—Cholecalciferol—osteoporosis	0.0254	0.0361	CbGbCtD
Cyclophosphamide—CYP3A5—Estradiol—osteoporosis	0.0254	0.0361	CbGbCtD
Cyclophosphamide—CYP2C8—Estradiol—osteoporosis	0.0244	0.0347	CbGbCtD
Cyclophosphamide—CYP3A4—Calcitriol—osteoporosis	0.0238	0.0339	CbGbCtD
Cyclophosphamide—CYP3A4—Estropipate—osteoporosis	0.0238	0.0339	CbGbCtD
Cyclophosphamide—CYP2C9—Cholecalciferol—osteoporosis	0.0211	0.03	CbGbCtD
Cyclophosphamide—CYP2C19—Estradiol—osteoporosis	0.0205	0.0291	CbGbCtD
Cyclophosphamide—CYP2D6—Cholecalciferol—osteoporosis	0.0193	0.0274	CbGbCtD
Cyclophosphamide—CYP3A4—Ergocalciferol—osteoporosis	0.0191	0.0271	CbGbCtD
Cyclophosphamide—ABCB1—Conjugated Estrogens—osteoporosis	0.0188	0.0267	CbGbCtD
Cyclophosphamide—CYP2C9—Estradiol—osteoporosis	0.017	0.0242	CbGbCtD
Cyclophosphamide—ABCB1—Estradiol—osteoporosis	0.0165	0.0235	CbGbCtD
Cyclophosphamide—CYP3A4—Raloxifene—osteoporosis	0.0159	0.0226	CbGbCtD
Cyclophosphamide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0154	0.0218	CbGbCtD
Cyclophosphamide—CYP3A4—Cholecalciferol—osteoporosis	0.0123	0.0175	CbGbCtD
Cyclophosphamide—CYP3A4—Conjugated Estrogens—osteoporosis	0.0113	0.016	CbGbCtD
Cyclophosphamide—CYP3A4—Estradiol—osteoporosis	0.0099	0.0141	CbGbCtD
Cyclophosphamide—Body temperature increased—Alendronate—osteoporosis	0.000201	0.000741	CcSEcCtD
Cyclophosphamide—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000201	0.000741	CcSEcCtD
Cyclophosphamide—Shock—Risedronate—osteoporosis	0.000201	0.00074	CcSEcCtD
Cyclophosphamide—Anaemia—Zoledronate—osteoporosis	0.000201	0.00074	CcSEcCtD
Cyclophosphamide—Discomfort—Pamidronate—osteoporosis	0.0002	0.000737	CcSEcCtD
Cyclophosphamide—Agitation—Zoledronate—osteoporosis	0.0002	0.000736	CcSEcCtD
Cyclophosphamide—Body temperature increased—Raloxifene—osteoporosis	0.000198	0.000729	CcSEcCtD
Cyclophosphamide—Vision blurred—Conjugated Estrogens—osteoporosis	0.000197	0.000726	CcSEcCtD
Cyclophosphamide—Urticaria—Ibandronate—osteoporosis	0.000197	0.000725	CcSEcCtD
Cyclophosphamide—Malaise—Zoledronate—osteoporosis	0.000196	0.000722	CcSEcCtD
Cyclophosphamide—Body temperature increased—Ibandronate—osteoporosis	0.000196	0.000722	CcSEcCtD
Cyclophosphamide—Confusional state—Pamidronate—osteoporosis	0.000196	0.000721	CcSEcCtD
Cyclophosphamide—Leukopenia—Zoledronate—osteoporosis	0.000194	0.000716	CcSEcCtD
Cyclophosphamide—Oedema—Pamidronate—osteoporosis	0.000194	0.000715	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Pamidronate—osteoporosis	0.000194	0.000715	CcSEcCtD
Cyclophosphamide—Haemoglobin—Estradiol—osteoporosis	0.000193	0.000712	CcSEcCtD
Cyclophosphamide—Infection—Pamidronate—osteoporosis	0.000193	0.00071	CcSEcCtD
Cyclophosphamide—Rhinitis—Estradiol—osteoporosis	0.000193	0.00071	CcSEcCtD
Cyclophosphamide—Urticaria—Calcitriol—osteoporosis	0.000193	0.00071	CcSEcCtD
Cyclophosphamide—Hepatitis—Estradiol—osteoporosis	0.000192	0.000709	CcSEcCtD
Cyclophosphamide—Haemorrhage—Estradiol—osteoporosis	0.000192	0.000709	CcSEcCtD
Cyclophosphamide—Palpitations—Zoledronate—osteoporosis	0.000192	0.000707	CcSEcCtD
Cyclophosphamide—Body temperature increased—Calcitriol—osteoporosis	0.000192	0.000706	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Estradiol—osteoporosis	0.000191	0.000705	CcSEcCtD
Cyclophosphamide—Shock—Pamidronate—osteoporosis	0.000191	0.000704	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Estropipate—osteoporosis	0.00019	0.000701	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Pamidronate—osteoporosis	0.00019	0.0007	CcSEcCtD
Cyclophosphamide—Vomiting—Etidronic acid—osteoporosis	0.00019	0.0007	CcSEcCtD
Cyclophosphamide—Cough—Zoledronate—osteoporosis	0.00019	0.000698	CcSEcCtD
Cyclophosphamide—Tachycardia—Pamidronate—osteoporosis	0.000189	0.000698	CcSEcCtD
Cyclophosphamide—Rash—Etidronic acid—osteoporosis	0.000188	0.000694	CcSEcCtD
Cyclophosphamide—Convulsion—Zoledronate—osteoporosis	0.000188	0.000693	CcSEcCtD
Cyclophosphamide—Dermatitis—Etidronic acid—osteoporosis	0.000188	0.000693	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Pamidronate—osteoporosis	0.000188	0.000691	CcSEcCtD
Cyclophosphamide—Hypertension—Zoledronate—osteoporosis	0.000188	0.000691	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Alendronate—osteoporosis	0.000188	0.000691	CcSEcCtD
Cyclophosphamide—Headache—Etidronic acid—osteoporosis	0.000187	0.000689	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000186	0.000685	CcSEcCtD
Cyclophosphamide—Asthenia—Estropipate—osteoporosis	0.000185	0.000683	CcSEcCtD
Cyclophosphamide—Visual impairment—Estradiol—osteoporosis	0.000185	0.000683	CcSEcCtD
Cyclophosphamide—Anorexia—Pamidronate—osteoporosis	0.000185	0.000682	CcSEcCtD
Cyclophosphamide—Chest pain—Zoledronate—osteoporosis	0.000185	0.000681	CcSEcCtD
Cyclophosphamide—Myalgia—Zoledronate—osteoporosis	0.000185	0.000681	CcSEcCtD
Cyclophosphamide—Arthralgia—Zoledronate—osteoporosis	0.000185	0.000681	CcSEcCtD
Cyclophosphamide—Palpitations—Conjugated Estrogens—osteoporosis	0.000185	0.000681	CcSEcCtD
Cyclophosphamide—Paraesthesia—Risedronate—osteoporosis	0.000183	0.000675	CcSEcCtD
Cyclophosphamide—Pruritus—Estropipate—osteoporosis	0.000183	0.000673	CcSEcCtD
Cyclophosphamide—Discomfort—Zoledronate—osteoporosis	0.000183	0.000673	CcSEcCtD
Cyclophosphamide—Asthenia—Alendronate—osteoporosis	0.000183	0.000673	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Ibandronate—osteoporosis	0.000183	0.000673	CcSEcCtD
Cyclophosphamide—Cough—Conjugated Estrogens—osteoporosis	0.000183	0.000672	CcSEcCtD
Cyclophosphamide—Dyspnoea—Risedronate—osteoporosis	0.000182	0.000671	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Estradiol—osteoporosis	0.000182	0.00067	CcSEcCtD
Cyclophosphamide—Hypotension—Pamidronate—osteoporosis	0.000181	0.000668	CcSEcCtD
Cyclophosphamide—Convulsion—Conjugated Estrogens—osteoporosis	0.000181	0.000668	CcSEcCtD
Cyclophosphamide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000181	0.000665	CcSEcCtD
Cyclophosphamide—Pruritus—Alendronate—osteoporosis	0.00018	0.000663	CcSEcCtD
Cyclophosphamide—Tinnitus—Estradiol—osteoporosis	0.000179	0.000661	CcSEcCtD
Cyclophosphamide—Constipation—Ethinyl Estradiol—osteoporosis	0.000179	0.00066	CcSEcCtD
Cyclophosphamide—Confusional state—Zoledronate—osteoporosis	0.000179	0.000659	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Calcitriol—osteoporosis	0.000179	0.000658	CcSEcCtD
Cyclophosphamide—Flushing—Estradiol—osteoporosis	0.000179	0.000658	CcSEcCtD
Cyclophosphamide—Myalgia—Conjugated Estrogens—osteoporosis	0.000178	0.000656	CcSEcCtD
Cyclophosphamide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000178	0.000656	CcSEcCtD
Cyclophosphamide—Chest pain—Conjugated Estrogens—osteoporosis	0.000178	0.000656	CcSEcCtD
Cyclophosphamide—Asthenia—Ibandronate—osteoporosis	0.000178	0.000655	CcSEcCtD
Cyclophosphamide—Nausea—Etidronic acid—osteoporosis	0.000177	0.000654	CcSEcCtD
Cyclophosphamide—Oedema—Zoledronate—osteoporosis	0.000177	0.000653	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Zoledronate—osteoporosis	0.000177	0.000653	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000177	0.000652	CcSEcCtD
Cyclophosphamide—Diarrhoea—Estropipate—osteoporosis	0.000177	0.000651	CcSEcCtD
Cyclophosphamide—Infection—Zoledronate—osteoporosis	0.000176	0.000649	CcSEcCtD
Cyclophosphamide—Fatigue—Risedronate—osteoporosis	0.000176	0.000649	CcSEcCtD
Cyclophosphamide—Pruritus—Ibandronate—osteoporosis	0.000175	0.000646	CcSEcCtD
Cyclophosphamide—Pain—Risedronate—osteoporosis	0.000175	0.000643	CcSEcCtD
Cyclophosphamide—Constipation—Risedronate—osteoporosis	0.000175	0.000643	CcSEcCtD
Cyclophosphamide—Shock—Zoledronate—osteoporosis	0.000174	0.000643	CcSEcCtD
Cyclophosphamide—Paraesthesia—Pamidronate—osteoporosis	0.000174	0.000642	CcSEcCtD
Cyclophosphamide—Diarrhoea—Alendronate—osteoporosis	0.000174	0.000641	CcSEcCtD
Cyclophosphamide—Asthenia—Calcitriol—osteoporosis	0.000174	0.000641	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Zoledronate—osteoporosis	0.000174	0.00064	CcSEcCtD
Cyclophosphamide—Dyspnoea—Pamidronate—osteoporosis	0.000173	0.000638	CcSEcCtD
Cyclophosphamide—Tachycardia—Zoledronate—osteoporosis	0.000173	0.000638	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000173	0.000636	CcSEcCtD
Cyclophosphamide—Chills—Estradiol—osteoporosis	0.000173	0.000636	CcSEcCtD
Cyclophosphamide—Pruritus—Calcitriol—osteoporosis	0.000172	0.000632	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Zoledronate—osteoporosis	0.000171	0.000631	CcSEcCtD
Cyclophosphamide—Diarrhoea—Raloxifene—osteoporosis	0.000171	0.000631	CcSEcCtD
Cyclophosphamide—Dizziness—Estropipate—osteoporosis	0.000171	0.000629	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000171	0.000629	CcSEcCtD
Cyclophosphamide—Oedema—Conjugated Estrogens—osteoporosis	0.000171	0.000629	CcSEcCtD
Cyclophosphamide—Alopecia—Estradiol—osteoporosis	0.00017	0.000626	CcSEcCtD
Cyclophosphamide—Infection—Conjugated Estrogens—osteoporosis	0.00017	0.000625	CcSEcCtD
Cyclophosphamide—Diarrhoea—Ibandronate—osteoporosis	0.00017	0.000625	CcSEcCtD
Cyclophosphamide—Anorexia—Zoledronate—osteoporosis	0.000169	0.000623	CcSEcCtD
Cyclophosphamide—Decreased appetite—Pamidronate—osteoporosis	0.000169	0.000622	CcSEcCtD
Cyclophosphamide—Dizziness—Alendronate—osteoporosis	0.000168	0.00062	CcSEcCtD
Cyclophosphamide—Shock—Conjugated Estrogens—osteoporosis	0.000168	0.000619	CcSEcCtD
Cyclophosphamide—Erythema—Estradiol—osteoporosis	0.000167	0.000617	CcSEcCtD
Cyclophosphamide—Fatigue—Pamidronate—osteoporosis	0.000167	0.000617	CcSEcCtD
Cyclophosphamide—Tachycardia—Conjugated Estrogens—osteoporosis	0.000167	0.000614	CcSEcCtD
Cyclophosphamide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000166	0.000613	CcSEcCtD
Cyclophosphamide—Constipation—Pamidronate—osteoporosis	0.000166	0.000612	CcSEcCtD
Cyclophosphamide—Pain—Pamidronate—osteoporosis	0.000166	0.000612	CcSEcCtD
Cyclophosphamide—Diarrhoea—Calcitriol—osteoporosis	0.000166	0.000611	CcSEcCtD
Cyclophosphamide—Hypotension—Zoledronate—osteoporosis	0.000166	0.00061	CcSEcCtD
Cyclophosphamide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000166	0.00061	CcSEcCtD
Cyclophosphamide—Dizziness—Raloxifene—osteoporosis	0.000166	0.00061	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000165	0.000608	CcSEcCtD
Cyclophosphamide—Vomiting—Estropipate—osteoporosis	0.000164	0.000605	CcSEcCtD
Cyclophosphamide—Dysgeusia—Estradiol—osteoporosis	0.000164	0.000604	CcSEcCtD
Cyclophosphamide—Dizziness—Ibandronate—osteoporosis	0.000164	0.000604	CcSEcCtD
Cyclophosphamide—Rash—Estropipate—osteoporosis	0.000163	0.0006	CcSEcCtD
Cyclophosphamide—Dermatitis—Estropipate—osteoporosis	0.000163	0.0006	CcSEcCtD
Cyclophosphamide—Anorexia—Conjugated Estrogens—osteoporosis	0.000163	0.0006	CcSEcCtD
Cyclophosphamide—Urticaria—Risedronate—osteoporosis	0.000162	0.000598	CcSEcCtD
Cyclophosphamide—Headache—Estropipate—osteoporosis	0.000162	0.000596	CcSEcCtD
Cyclophosphamide—Vomiting—Alendronate—osteoporosis	0.000162	0.000596	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000162	0.000595	CcSEcCtD
Cyclophosphamide—Body temperature increased—Risedronate—osteoporosis	0.000161	0.000595	CcSEcCtD
Cyclophosphamide—Muscle spasms—Estradiol—osteoporosis	0.000161	0.000593	CcSEcCtD
Cyclophosphamide—Rash—Alendronate—osteoporosis	0.00016	0.000591	CcSEcCtD
Cyclophosphamide—Dermatitis—Alendronate—osteoporosis	0.00016	0.000591	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Pamidronate—osteoporosis	0.00016	0.000589	CcSEcCtD
Cyclophosphamide—Hypotension—Conjugated Estrogens—osteoporosis	0.00016	0.000588	CcSEcCtD
Cyclophosphamide—Headache—Alendronate—osteoporosis	0.000159	0.000587	CcSEcCtD
Cyclophosphamide—Paraesthesia—Zoledronate—osteoporosis	0.000159	0.000587	CcSEcCtD
Cyclophosphamide—Vomiting—Raloxifene—osteoporosis	0.000159	0.000586	CcSEcCtD
Cyclophosphamide—Dyspnoea—Zoledronate—osteoporosis	0.000158	0.000582	CcSEcCtD
Cyclophosphamide—Rash—Raloxifene—osteoporosis	0.000158	0.000581	CcSEcCtD
Cyclophosphamide—Dermatitis—Raloxifene—osteoporosis	0.000158	0.000581	CcSEcCtD
Cyclophosphamide—Vomiting—Ibandronate—osteoporosis	0.000158	0.00058	CcSEcCtD
Cyclophosphamide—Tremor—Estradiol—osteoporosis	0.000157	0.000578	CcSEcCtD
Cyclophosphamide—Headache—Raloxifene—osteoporosis	0.000157	0.000578	CcSEcCtD
Cyclophosphamide—Rash—Ibandronate—osteoporosis	0.000156	0.000576	CcSEcCtD
Cyclophosphamide—Dermatitis—Ibandronate—osteoporosis	0.000156	0.000575	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000156	0.000573	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Estradiol—osteoporosis	0.000155	0.000572	CcSEcCtD
Cyclophosphamide—Headache—Ibandronate—osteoporosis	0.000155	0.000572	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000154	0.000568	CcSEcCtD
Cyclophosphamide—Vomiting—Calcitriol—osteoporosis	0.000154	0.000568	CcSEcCtD
Cyclophosphamide—Decreased appetite—Zoledronate—osteoporosis	0.000154	0.000568	CcSEcCtD
Cyclophosphamide—Agitation—Estradiol—osteoporosis	0.000154	0.000567	CcSEcCtD
Cyclophosphamide—Nausea—Estropipate—osteoporosis	0.000153	0.000565	CcSEcCtD
Cyclophosphamide—Body temperature increased—Pamidronate—osteoporosis	0.000153	0.000565	CcSEcCtD
Cyclophosphamide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000153	0.000565	CcSEcCtD
Cyclophosphamide—Rash—Calcitriol—osteoporosis	0.000153	0.000563	CcSEcCtD
Cyclophosphamide—Fatigue—Zoledronate—osteoporosis	0.000153	0.000563	CcSEcCtD
Cyclophosphamide—Dermatitis—Calcitriol—osteoporosis	0.000153	0.000563	CcSEcCtD
Cyclophosphamide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000152	0.000561	CcSEcCtD
Cyclophosphamide—Headache—Calcitriol—osteoporosis	0.000152	0.00056	CcSEcCtD
Cyclophosphamide—Pain—Zoledronate—osteoporosis	0.000152	0.000559	CcSEcCtD
Cyclophosphamide—Constipation—Zoledronate—osteoporosis	0.000152	0.000559	CcSEcCtD
Cyclophosphamide—Nausea—Alendronate—osteoporosis	0.000151	0.000557	CcSEcCtD
Cyclophosphamide—Malaise—Estradiol—osteoporosis	0.000151	0.000556	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Risedronate—osteoporosis	0.00015	0.000554	CcSEcCtD
Cyclophosphamide—Asthenia—Ethinyl Estradiol—osteoporosis	0.00015	0.000554	CcSEcCtD
Cyclophosphamide—Nausea—Raloxifene—osteoporosis	0.000149	0.000548	CcSEcCtD
Cyclophosphamide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000148	0.000547	CcSEcCtD
Cyclophosphamide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000148	0.000546	CcSEcCtD
Cyclophosphamide—Palpitations—Estradiol—osteoporosis	0.000148	0.000545	CcSEcCtD
Cyclophosphamide—Fatigue—Conjugated Estrogens—osteoporosis	0.000147	0.000542	CcSEcCtD
Cyclophosphamide—Nausea—Ibandronate—osteoporosis	0.000147	0.000542	CcSEcCtD
Cyclophosphamide—Asthenia—Risedronate—osteoporosis	0.000147	0.00054	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Zoledronate—osteoporosis	0.000146	0.000538	CcSEcCtD
Cyclophosphamide—Cough—Estradiol—osteoporosis	0.000146	0.000538	CcSEcCtD
Cyclophosphamide—Pain—Conjugated Estrogens—osteoporosis	0.000146	0.000538	CcSEcCtD
Cyclophosphamide—Constipation—Conjugated Estrogens—osteoporosis	0.000146	0.000538	CcSEcCtD
Cyclophosphamide—Hypertension—Estradiol—osteoporosis	0.000145	0.000533	CcSEcCtD
Cyclophosphamide—Pruritus—Risedronate—osteoporosis	0.000144	0.000532	CcSEcCtD
Cyclophosphamide—Nausea—Calcitriol—osteoporosis	0.000144	0.000531	CcSEcCtD
Cyclophosphamide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000143	0.000528	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Pamidronate—osteoporosis	0.000143	0.000527	CcSEcCtD
Cyclophosphamide—Chest pain—Estradiol—osteoporosis	0.000143	0.000525	CcSEcCtD
Cyclophosphamide—Arthralgia—Estradiol—osteoporosis	0.000143	0.000525	CcSEcCtD
Cyclophosphamide—Myalgia—Estradiol—osteoporosis	0.000143	0.000525	CcSEcCtD
Cyclophosphamide—Urticaria—Zoledronate—osteoporosis	0.000141	0.000519	CcSEcCtD
Cyclophosphamide—Discomfort—Estradiol—osteoporosis	0.000141	0.000519	CcSEcCtD
Cyclophosphamide—Body temperature increased—Zoledronate—osteoporosis	0.00014	0.000516	CcSEcCtD
Cyclophosphamide—Diarrhoea—Risedronate—osteoporosis	0.00014	0.000515	CcSEcCtD
Cyclophosphamide—Asthenia—Pamidronate—osteoporosis	0.000139	0.000513	CcSEcCtD
Cyclophosphamide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000139	0.00051	CcSEcCtD
Cyclophosphamide—Confusional state—Estradiol—osteoporosis	0.000138	0.000508	CcSEcCtD
Cyclophosphamide—Pruritus—Pamidronate—osteoporosis	0.000137	0.000506	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Estradiol—osteoporosis	0.000137	0.000503	CcSEcCtD
Cyclophosphamide—Oedema—Estradiol—osteoporosis	0.000137	0.000503	CcSEcCtD
Cyclophosphamide—Infection—Estradiol—osteoporosis	0.000136	0.0005	CcSEcCtD
Cyclophosphamide—Urticaria—Conjugated Estrogens—osteoporosis	0.000136	0.0005	CcSEcCtD
Cyclophosphamide—Dizziness—Risedronate—osteoporosis	0.000135	0.000497	CcSEcCtD
Cyclophosphamide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000135	0.000497	CcSEcCtD
Cyclophosphamide—Shock—Estradiol—osteoporosis	0.000134	0.000495	CcSEcCtD
Cyclophosphamide—Tachycardia—Estradiol—osteoporosis	0.000133	0.000491	CcSEcCtD
Cyclophosphamide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000133	0.000491	CcSEcCtD
Cyclophosphamide—Diarrhoea—Pamidronate—osteoporosis	0.000133	0.000489	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Estradiol—osteoporosis	0.000132	0.000487	CcSEcCtD
Cyclophosphamide—Rash—Ethinyl Estradiol—osteoporosis	0.000132	0.000486	CcSEcCtD
Cyclophosphamide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000132	0.000486	CcSEcCtD
Cyclophosphamide—Headache—Ethinyl Estradiol—osteoporosis	0.000131	0.000483	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Zoledronate—osteoporosis	0.000131	0.000481	CcSEcCtD
Cyclophosphamide—Vomiting—Risedronate—osteoporosis	0.00013	0.000478	CcSEcCtD
Cyclophosphamide—Rash—Risedronate—osteoporosis	0.000129	0.000474	CcSEcCtD
Cyclophosphamide—Dermatitis—Risedronate—osteoporosis	0.000129	0.000474	CcSEcCtD
Cyclophosphamide—Dizziness—Pamidronate—osteoporosis	0.000128	0.000473	CcSEcCtD
Cyclophosphamide—Headache—Risedronate—osteoporosis	0.000128	0.000471	CcSEcCtD
Cyclophosphamide—Asthenia—Zoledronate—osteoporosis	0.000127	0.000469	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000126	0.000463	CcSEcCtD
Cyclophosphamide—Pruritus—Zoledronate—osteoporosis	0.000125	0.000462	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000125	0.000459	CcSEcCtD
Cyclophosphamide—Nausea—Ethinyl Estradiol—osteoporosis	0.000124	0.000458	CcSEcCtD
Cyclophosphamide—Vomiting—Pamidronate—osteoporosis	0.000123	0.000455	CcSEcCtD
Cyclophosphamide—Paraesthesia—Estradiol—osteoporosis	0.000123	0.000452	CcSEcCtD
Cyclophosphamide—Asthenia—Conjugated Estrogens—osteoporosis	0.000123	0.000451	CcSEcCtD
Cyclophosphamide—Rash—Pamidronate—osteoporosis	0.000122	0.000451	CcSEcCtD
Cyclophosphamide—Dermatitis—Pamidronate—osteoporosis	0.000122	0.00045	CcSEcCtD
Cyclophosphamide—Dyspnoea—Estradiol—osteoporosis	0.000122	0.000449	CcSEcCtD
Cyclophosphamide—Headache—Pamidronate—osteoporosis	0.000122	0.000448	CcSEcCtD
Cyclophosphamide—Diarrhoea—Zoledronate—osteoporosis	0.000121	0.000447	CcSEcCtD
Cyclophosphamide—Nausea—Risedronate—osteoporosis	0.000121	0.000447	CcSEcCtD
Cyclophosphamide—Pruritus—Conjugated Estrogens—osteoporosis	0.000121	0.000445	CcSEcCtD
Cyclophosphamide—Decreased appetite—Estradiol—osteoporosis	0.000119	0.000438	CcSEcCtD
Cyclophosphamide—Fatigue—Estradiol—osteoporosis	0.000118	0.000434	CcSEcCtD
Cyclophosphamide—Dizziness—Zoledronate—osteoporosis	0.000117	0.000432	CcSEcCtD
Cyclophosphamide—Constipation—Estradiol—osteoporosis	0.000117	0.00043	CcSEcCtD
Cyclophosphamide—Pain—Estradiol—osteoporosis	0.000117	0.00043	CcSEcCtD
Cyclophosphamide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000117	0.00043	CcSEcCtD
Cyclophosphamide—Nausea—Pamidronate—osteoporosis	0.000115	0.000425	CcSEcCtD
Cyclophosphamide—Dizziness—Conjugated Estrogens—osteoporosis	0.000113	0.000416	CcSEcCtD
Cyclophosphamide—Vomiting—Zoledronate—osteoporosis	0.000113	0.000415	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Estradiol—osteoporosis	0.000113	0.000415	CcSEcCtD
Cyclophosphamide—Rash—Zoledronate—osteoporosis	0.000112	0.000412	CcSEcCtD
Cyclophosphamide—Dermatitis—Zoledronate—osteoporosis	0.000112	0.000411	CcSEcCtD
Cyclophosphamide—Headache—Zoledronate—osteoporosis	0.000111	0.000409	CcSEcCtD
Cyclophosphamide—Vomiting—Conjugated Estrogens—osteoporosis	0.000109	0.0004	CcSEcCtD
Cyclophosphamide—Urticaria—Estradiol—osteoporosis	0.000109	0.0004	CcSEcCtD
Cyclophosphamide—Body temperature increased—Estradiol—osteoporosis	0.000108	0.000398	CcSEcCtD
Cyclophosphamide—Rash—Conjugated Estrogens—osteoporosis	0.000108	0.000397	CcSEcCtD
Cyclophosphamide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000108	0.000396	CcSEcCtD
Cyclophosphamide—Headache—Conjugated Estrogens—osteoporosis	0.000107	0.000394	CcSEcCtD
Cyclophosphamide—Nausea—Zoledronate—osteoporosis	0.000105	0.000388	CcSEcCtD
Cyclophosphamide—Nausea—Conjugated Estrogens—osteoporosis	0.000101	0.000374	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Estradiol—osteoporosis	0.000101	0.000371	CcSEcCtD
Cyclophosphamide—Asthenia—Estradiol—osteoporosis	9.8e-05	0.000361	CcSEcCtD
Cyclophosphamide—Pruritus—Estradiol—osteoporosis	9.67e-05	0.000356	CcSEcCtD
Cyclophosphamide—Diarrhoea—Estradiol—osteoporosis	9.35e-05	0.000344	CcSEcCtD
Cyclophosphamide—Dizziness—Estradiol—osteoporosis	9.04e-05	0.000333	CcSEcCtD
Cyclophosphamide—Vomiting—Estradiol—osteoporosis	8.69e-05	0.00032	CcSEcCtD
Cyclophosphamide—Rash—Estradiol—osteoporosis	8.62e-05	0.000317	CcSEcCtD
Cyclophosphamide—Dermatitis—Estradiol—osteoporosis	8.61e-05	0.000317	CcSEcCtD
Cyclophosphamide—Headache—Estradiol—osteoporosis	8.56e-05	0.000315	CcSEcCtD
Cyclophosphamide—Nausea—Estradiol—osteoporosis	8.12e-05	0.000299	CcSEcCtD
Cyclophosphamide—CYP2A6—Metabolism—MGLL—osteoporosis	2.67e-05	0.00106	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.66e-05	0.00106	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ATIC—osteoporosis	2.6e-05	0.00104	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PNP—osteoporosis	2.6e-05	0.00104	CbGpPWpGaD
Cyclophosphamide—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	2.59e-05	0.00103	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ATIC—osteoporosis	2.54e-05	0.00101	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PNP—osteoporosis	2.54e-05	0.00101	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PKM—osteoporosis	2.54e-05	0.00101	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—FDPS—osteoporosis	2.54e-05	0.00101	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—TGFB1—osteoporosis	2.52e-05	0.001	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.48e-05	0.000991	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—IDH2—osteoporosis	2.47e-05	0.000988	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PGLS—osteoporosis	2.4e-05	0.00096	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GPD2—osteoporosis	2.4e-05	0.00096	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.4e-05	0.000959	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—POMC—osteoporosis	2.4e-05	0.000958	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	2.39e-05	0.000956	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.37e-05	0.000945	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—TNF—osteoporosis	2.35e-05	0.000938	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CYP27A1—osteoporosis	2.33e-05	0.000929	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—ENO1—osteoporosis	2.3e-05	0.000918	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—IDH2—osteoporosis	2.27e-05	0.000905	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PSMA2—osteoporosis	2.27e-05	0.000904	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PSMA5—osteoporosis	2.27e-05	0.000904	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PKM—osteoporosis	2.26e-05	0.000903	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—FDPS—osteoporosis	2.26e-05	0.000903	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.26e-05	0.000903	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ACP5—osteoporosis	2.26e-05	0.000903	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PKM—osteoporosis	2.21e-05	0.000882	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—FDPS—osteoporosis	2.21e-05	0.000882	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CA2—osteoporosis	2.21e-05	0.000881	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—OXCT1—osteoporosis	2.21e-05	0.000881	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—POMC—osteoporosis	2.21e-05	0.000881	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ATIC—osteoporosis	2.2e-05	0.000878	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PNP—osteoporosis	2.2e-05	0.000878	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—POMC—osteoporosis	2.19e-05	0.000873	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CA2—osteoporosis	2.16e-05	0.000862	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—OXCT1—osteoporosis	2.16e-05	0.000862	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—MGLL—osteoporosis	2.15e-05	0.000859	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PGLS—osteoporosis	2.15e-05	0.000856	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GPD2—osteoporosis	2.15e-05	0.000856	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP27A1—osteoporosis	2.13e-05	0.000851	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—TPI1—osteoporosis	2.1e-05	0.00084	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—MGLL—osteoporosis	2.1e-05	0.00084	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PGLS—osteoporosis	2.09e-05	0.000836	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GPD2—osteoporosis	2.09e-05	0.000836	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—FDPS—osteoporosis	2.08e-05	0.000831	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PKM—osteoporosis	2.08e-05	0.000831	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ACP5—osteoporosis	2.07e-05	0.000828	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.07e-05	0.000827	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—FDPS—osteoporosis	2.06e-05	0.000824	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PKM—osteoporosis	2.06e-05	0.000824	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—P4HB—osteoporosis	1.98e-05	0.00079	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PGLS—osteoporosis	1.97e-05	0.000788	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GPD2—osteoporosis	1.97e-05	0.000788	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ATIC—osteoporosis	1.96e-05	0.000783	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PNP—osteoporosis	1.96e-05	0.000783	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PGLS—osteoporosis	1.96e-05	0.000781	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GPD2—osteoporosis	1.96e-05	0.000781	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GAPDH—osteoporosis	1.94e-05	0.000775	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—TPI1—osteoporosis	1.93e-05	0.00077	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ATIC—osteoporosis	1.92e-05	0.000765	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PNP—osteoporosis	1.92e-05	0.000765	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—RAP1A—osteoporosis	1.89e-05	0.000755	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—OXCT1—osteoporosis	1.87e-05	0.000746	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CA2—osteoporosis	1.87e-05	0.000746	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CYP19A1—osteoporosis	1.84e-05	0.000734	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—IDH2—osteoporosis	1.83e-05	0.00073	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—MGLL—osteoporosis	1.82e-05	0.000727	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—P4HB—osteoporosis	1.81e-05	0.000724	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PNP—osteoporosis	1.8e-05	0.00072	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ATIC—osteoporosis	1.8e-05	0.00072	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ATIC—osteoporosis	1.79e-05	0.000714	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PNP—osteoporosis	1.79e-05	0.000714	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—IDH2—osteoporosis	1.79e-05	0.000714	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GAPDH—osteoporosis	1.78e-05	0.00071	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—RAP1A—osteoporosis	1.73e-05	0.000692	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP27A1—osteoporosis	1.72e-05	0.000687	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.72e-05	0.000686	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.68e-05	0.000671	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ACP5—osteoporosis	1.67e-05	0.000668	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CA2—osteoporosis	1.67e-05	0.000666	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—OXCT1—osteoporosis	1.67e-05	0.000666	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ACP5—osteoporosis	1.64e-05	0.000653	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CA2—osteoporosis	1.63e-05	0.00065	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—OXCT1—osteoporosis	1.63e-05	0.00065	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—MGLL—osteoporosis	1.63e-05	0.000649	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—MGLL—osteoporosis	1.59e-05	0.000634	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—TPI1—osteoporosis	1.56e-05	0.000621	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—IDH2—osteoporosis	1.55e-05	0.000618	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CA2—osteoporosis	1.53e-05	0.000613	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—OXCT1—osteoporosis	1.53e-05	0.000613	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.53e-05	0.000612	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ENO1—osteoporosis	1.53e-05	0.00061	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CA2—osteoporosis	1.52e-05	0.000607	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—OXCT1—osteoporosis	1.52e-05	0.000607	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—TPI1—osteoporosis	1.52e-05	0.000607	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PSMA5—osteoporosis	1.51e-05	0.000601	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PSMA2—osteoporosis	1.51e-05	0.000601	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—ADCY5—osteoporosis	1.5e-05	0.000599	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—GPX1—osteoporosis	1.5e-05	0.000597	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—MGLL—osteoporosis	1.5e-05	0.000597	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—MGLL—osteoporosis	1.48e-05	0.000592	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—P4HB—osteoporosis	1.46e-05	0.000584	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.46e-05	0.000581	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—POMC—osteoporosis	1.44e-05	0.000576	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GAPDH—osteoporosis	1.44e-05	0.000573	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—P4HB—osteoporosis	1.43e-05	0.000571	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ACP5—osteoporosis	1.42e-05	0.000566	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GAPDH—osteoporosis	1.4e-05	0.00056	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ENO1—osteoporosis	1.4e-05	0.000559	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.4e-05	0.000558	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—RAP1A—osteoporosis	1.4e-05	0.000558	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.4e-05	0.000558	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—IDH2—osteoporosis	1.38e-05	0.000552	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—MTHFR—osteoporosis	1.38e-05	0.000551	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PSMA5—osteoporosis	1.38e-05	0.000551	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PSMA2—osteoporosis	1.38e-05	0.000551	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—RAP1A—osteoporosis	1.37e-05	0.000546	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PKM—osteoporosis	1.36e-05	0.000543	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—FDPS—osteoporosis	1.36e-05	0.000543	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—IDH2—osteoporosis	1.35e-05	0.000539	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—TPI1—osteoporosis	1.32e-05	0.000526	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.3e-05	0.000519	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GPD2—osteoporosis	1.29e-05	0.000515	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PGLS—osteoporosis	1.29e-05	0.000515	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—IDH2—osteoporosis	1.27e-05	0.000508	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP27A1—osteoporosis	1.27e-05	0.000506	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ACP5—osteoporosis	1.26e-05	0.000505	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—IDH2—osteoporosis	1.26e-05	0.000503	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.25e-05	0.000498	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.25e-05	0.000497	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.24e-05	0.000496	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—P4HB—osteoporosis	1.24e-05	0.000494	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ACP5—osteoporosis	1.23e-05	0.000493	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.22e-05	0.000488	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GAPDH—osteoporosis	1.22e-05	0.000485	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.2e-05	0.000477	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.19e-05	0.000473	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—RAP1A—osteoporosis	1.18e-05	0.000473	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PNP—osteoporosis	1.18e-05	0.000471	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ATIC—osteoporosis	1.18e-05	0.000471	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—TPI1—osteoporosis	1.18e-05	0.000469	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ACP5—osteoporosis	1.16e-05	0.000464	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.16e-05	0.000464	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.16e-05	0.000463	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ACP5—osteoporosis	1.15e-05	0.00046	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—TPI1—osteoporosis	1.15e-05	0.000458	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.14e-05	0.000454	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ENO1—osteoporosis	1.13e-05	0.000451	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP19A1—osteoporosis	1.12e-05	0.000447	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PSMA2—osteoporosis	1.11e-05	0.000445	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PSMA5—osteoporosis	1.11e-05	0.000445	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—P4HB—osteoporosis	1.11e-05	0.000441	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ENO1—osteoporosis	1.1e-05	0.000441	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—POMC—osteoporosis	1.1e-05	0.000441	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PSMA5—osteoporosis	1.09e-05	0.000435	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PSMA2—osteoporosis	1.09e-05	0.000435	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GAPDH—osteoporosis	1.08e-05	0.000433	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—TPI1—osteoporosis	1.08e-05	0.000432	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—P4HB—osteoporosis	1.08e-05	0.000431	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—TPI1—osteoporosis	1.07e-05	0.000428	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GAPDH—osteoporosis	1.06e-05	0.000423	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—RAP1A—osteoporosis	1.06e-05	0.000422	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.03e-05	0.000412	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—RAP1A—osteoporosis	1.03e-05	0.000412	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—P4HB—osteoporosis	1.02e-05	0.000406	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—P4HB—osteoporosis	1.01e-05	0.000402	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CA2—osteoporosis	1e-05	0.000401	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—OXCT1—osteoporosis	1e-05	0.000401	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ADCY5—osteoporosis	9.98e-06	0.000399	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GAPDH—osteoporosis	9.98e-06	0.000398	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GPX1—osteoporosis	9.95e-06	0.000397	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GAPDH—osteoporosis	9.89e-06	0.000395	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MGLL—osteoporosis	9.78e-06	0.00039	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—RAP1A—osteoporosis	9.72e-06	0.000388	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—RAP1A—osteoporosis	9.63e-06	0.000385	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ENO1—osteoporosis	9.57e-06	0.000382	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PSMA5—osteoporosis	9.43e-06	0.000376	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PSMA2—osteoporosis	9.43e-06	0.000376	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.21e-06	0.000368	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—MTHFR—osteoporosis	9.18e-06	0.000367	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ADCY5—osteoporosis	9.15e-06	0.000365	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GPX1—osteoporosis	9.12e-06	0.000364	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP19A1—osteoporosis	9.04e-06	0.000361	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP19A1—osteoporosis	8.83e-06	0.000353	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ENO1—osteoporosis	8.54e-06	0.000341	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PSMA2—osteoporosis	8.42e-06	0.000336	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PSMA5—osteoporosis	8.42e-06	0.000336	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—MTHFR—osteoporosis	8.42e-06	0.000336	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.4e-06	0.000335	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ENO1—osteoporosis	8.34e-06	0.000333	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—IDH2—osteoporosis	8.31e-06	0.000332	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PSMA2—osteoporosis	8.21e-06	0.000328	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PSMA5—osteoporosis	8.21e-06	0.000328	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ENO1—osteoporosis	7.86e-06	0.000314	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP27A1—osteoporosis	7.82e-06	0.000312	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ENO1—osteoporosis	7.79e-06	0.000311	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PSMA2—osteoporosis	7.74e-06	0.000309	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PSMA5—osteoporosis	7.74e-06	0.000309	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PSMA2—osteoporosis	7.67e-06	0.000306	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PSMA5—osteoporosis	7.67e-06	0.000306	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP19A1—osteoporosis	7.65e-06	0.000305	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ACP5—osteoporosis	7.6e-06	0.000304	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ADCY5—osteoporosis	7.38e-06	0.000295	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GPX1—osteoporosis	7.36e-06	0.000294	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—POMC—osteoporosis	7.34e-06	0.000293	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ADCY5—osteoporosis	7.22e-06	0.000288	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GPX1—osteoporosis	7.19e-06	0.000287	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—TPI1—osteoporosis	7.07e-06	0.000282	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP19A1—osteoporosis	6.83e-06	0.000273	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—MTHFR—osteoporosis	6.79e-06	0.000271	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—POMC—osteoporosis	6.73e-06	0.000269	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP19A1—osteoporosis	6.66e-06	0.000266	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—P4HB—osteoporosis	6.65e-06	0.000265	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—MTHFR—osteoporosis	6.64e-06	0.000265	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GAPDH—osteoporosis	6.52e-06	0.00026	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—RAP1A—osteoporosis	6.35e-06	0.000254	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP19A1—osteoporosis	6.28e-06	0.000251	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ADCY5—osteoporosis	6.25e-06	0.00025	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GPX1—osteoporosis	6.23e-06	0.000249	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP19A1—osteoporosis	6.23e-06	0.000249	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—MTHFR—osteoporosis	5.75e-06	0.000229	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ADCY5—osteoporosis	5.58e-06	0.000223	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GPX1—osteoporosis	5.56e-06	0.000222	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ADCY5—osteoporosis	5.45e-06	0.000217	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—POMC—osteoporosis	5.43e-06	0.000217	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GPX1—osteoporosis	5.43e-06	0.000217	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—POMC—osteoporosis	5.31e-06	0.000212	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ENO1—osteoporosis	5.14e-06	0.000205	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ADCY5—osteoporosis	5.13e-06	0.000205	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—MTHFR—osteoporosis	5.13e-06	0.000205	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GPX1—osteoporosis	5.11e-06	0.000204	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ADCY5—osteoporosis	5.09e-06	0.000203	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GPX1—osteoporosis	5.07e-06	0.000202	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PSMA2—osteoporosis	5.06e-06	0.000202	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PSMA5—osteoporosis	5.06e-06	0.000202	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—MTHFR—osteoporosis	5.01e-06	0.0002	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—MTHFR—osteoporosis	4.72e-06	0.000188	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—MTHFR—osteoporosis	4.68e-06	0.000187	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—POMC—osteoporosis	4.6e-06	0.000184	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.11e-06	0.000164	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—POMC—osteoporosis	4.1e-06	0.000164	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—POMC—osteoporosis	4.01e-06	0.00016	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—POMC—osteoporosis	3.77e-06	0.000151	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—POMC—osteoporosis	3.74e-06	0.000149	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ADCY5—osteoporosis	3.36e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GPX1—osteoporosis	3.34e-06	0.000133	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MTHFR—osteoporosis	3.09e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—POMC—osteoporosis	2.47e-06	9.85e-05	CbGpPWpGaD
